• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[慢性心力衰竭中的肥胖与心脏恶病质]

[Obesity and cardiac cachexia in chronic heart failure].

作者信息

Clauser M, Altenberger J

机构信息

Pensionsversicherungsanstalt, Sonderkrankenanstalt Rehabilitationszentrum Großgmain für Herz-Kreislauf- und neurologische Erkrankungen, Salzburgerstr. 520, A-5084, Großgmain, Österreich.

出版信息

Herz. 2013 Sep;38(6):610-7. doi: 10.1007/s00059-013-3885-0.

DOI:10.1007/s00059-013-3885-0
PMID:23897599
Abstract

Obesity as well as cardiac cachexia in heart failure patients are not fully understood and therefore of high scientific interest. Obesity as a common risk factor for cardiovascular disease is associated with a high mortality. In contrast obesity in patients suffering from chronic heart failure seems to be accompanied with a favorable outcome in contrast to people with normal weight, known as the obesity paradox. In the last decade there has been growing interest in cachexia, which is common in advanced stages of chronic diseases, such as heart failure, chronic obstructive pulmonary disease (COPD), cancer and renal failure and is associated with a poor prognosis. Until now cachexia has been underdiagnosed and undertreated. This review discusses the complex underlying pathomechanisms as well as potential therapeutic approaches.

摘要

心力衰竭患者的肥胖以及心源性恶病质尚未被完全理解,因此具有很高的科学研究价值。肥胖作为心血管疾病的常见危险因素,与高死亡率相关。相比之下,慢性心力衰竭患者的肥胖似乎与体重正常者相比有着较好的预后,这被称为肥胖悖论。在过去十年中,人们对恶病质的兴趣日益浓厚,恶病质在慢性疾病的晚期很常见,如心力衰竭、慢性阻塞性肺疾病(COPD)、癌症和肾衰竭,并且与不良预后相关。到目前为止,恶病质一直未得到充分诊断和治疗。本综述讨论了其复杂的潜在病理机制以及潜在的治疗方法。

相似文献

1
[Obesity and cardiac cachexia in chronic heart failure].[慢性心力衰竭中的肥胖与心脏恶病质]
Herz. 2013 Sep;38(6):610-7. doi: 10.1007/s00059-013-3885-0.
2
Publication trends in cachexia and sarcopenia in elderly heart failure patients.老年心力衰竭患者恶病质和肌肉减少症的发表趋势
Wien Klin Wochenschr. 2016 Dec;128(Suppl 7):446-454. doi: 10.1007/s00508-016-1126-2. Epub 2016 Nov 24.
3
Cardiac Cachexia Revisited: The Role of Wasting in Heart Failure.再谈心脏恶病质:消瘦在心力衰竭中的作用
Cardiol Clin. 2022 May;40(2):199-207. doi: 10.1016/j.ccl.2021.12.008.
4
Cardiac cachexia: hic et nunc: "hic et nunc" - here and now.心脏恶病质:此时此地:“hic et nunc”——此时此地。
Int J Cardiol. 2015 Dec 15;201:e1-12. doi: 10.1016/j.ijcard.2015.10.115. Epub 2015 Oct 23.
5
Obesity paradox, cachexia, frailty, and heart failure.肥胖悖论、恶病质、衰弱与心力衰竭。
Heart Fail Clin. 2014 Apr;10(2):319-26. doi: 10.1016/j.hfc.2013.12.002.
6
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.慢性心力衰竭中高血压、肥胖、糖尿病、高脂血症和代谢综合征合并症的共同风险及管理:美国心脏协会科学声明
Circulation. 2016 Dec 6;134(23):e535-e578. doi: 10.1161/CIR.0000000000000450. Epub 2016 Oct 31.
7
Cardiac Cachexia: A Well-Known but Challenging Complication of Heart Failure.心脏恶病质:心力衰竭的一种众所周知但极具挑战性的并发症。
Clin Interv Aging. 2020 Nov 2;15:2041-2051. doi: 10.2147/CIA.S273967. eCollection 2020.
8
Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee.心力衰竭患者的营养、肥胖和恶病质:美国心力衰竭学会科学声明委员会的共识声明。
J Card Fail. 2019 May;25(5):380-400. doi: 10.1016/j.cardfail.2019.03.007. Epub 2019 Mar 13.
9
Obesity and heart failure with preserved ejection fraction: A growing problem.肥胖与射血分数保留的心力衰竭:日益严重的问题。
Trends Cardiovasc Med. 2018 Jul;28(5):322-327. doi: 10.1016/j.tcm.2017.12.003. Epub 2017 Dec 14.
10
Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.慢性心力衰竭中的恶病质:内分泌决定因素和治疗观点。
Endocrine. 2013 Apr;43(2):253-65. doi: 10.1007/s12020-012-9767-z. Epub 2012 Aug 19.

引用本文的文献

1
Unraveling the Role of Epicardial Adipose Tissue in Coronary Artery Disease: Partners in Crime?解析心外膜脂肪组织在冠状动脉疾病中的作用:共犯?
Int J Mol Sci. 2020 Nov 23;21(22):8866. doi: 10.3390/ijms21228866.

本文引用的文献

1
Exercise training in chronic heart failure.慢性心力衰竭的运动训练。
Ther Adv Chronic Dis. 2013 May;4(3):105-17. doi: 10.1177/2040622313480382.
2
Endotoxin binding by sevelamer: potential impact on nutritional status.司维拉姆对内毒素的结合作用:对营养状况的潜在影响。
Int J Nephrol. 2013;2013:954956. doi: 10.1155/2013/954956. Epub 2013 Jan 17.
3
Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF).慢性心力衰竭患者的肌肉减少症:调查合并症加重心力衰竭的研究(SICA-HF)的结果。
Eur Heart J. 2013 Feb;34(7):512-9. doi: 10.1093/eurheartj/ehs381. Epub 2012 Nov 23.
4
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.《2012年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》:欧洲心脏病学会2012年急性和慢性心力衰竭诊断与治疗特别工作组编著。与欧洲心脏病学会心力衰竭协会(HFA)合作制定。
Eur Heart J. 2012 Jul;33(14):1787-847. doi: 10.1093/eurheartj/ehs104. Epub 2012 May 19.
5
Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial.Ghrelin 治疗伴有慢性阻塞性肺疾病的恶病质患者:一项多中心、随机、双盲、安慰剂对照试验。
PLoS One. 2012;7(5):e35708. doi: 10.1371/journal.pone.0035708. Epub 2012 May 1.
6
Leptin in anorexia and cachexia syndrome.厌食症和恶病质综合征中的瘦素
Int J Pept. 2012;2012:287457. doi: 10.1155/2012/287457. Epub 2012 Feb 8.
7
Abstracts of the 6th cachexia conference, milan, Italy, december 8-10, 2011.第六届恶病质会议摘要,意大利米兰,2011年12月8 - 10日。
J Cachexia Sarcopenia Muscle. 2011 Dec;2(4):209-61. doi: 10.1007/s13539-011-0045-3.
8
Obesity, health status, and 7-year mortality in percutaneous coronary intervention: in search of an explanation for the obesity paradox.肥胖、健康状况与经皮冠状动脉介入治疗后 7 年死亡率:探寻肥胖悖论的解释。
Int J Cardiol. 2013 Aug 20;167(4):1154-8. doi: 10.1016/j.ijcard.2012.03.105. Epub 2012 Apr 3.
9
Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference.恶病质治疗的最新进展:第六届恶病质会议要点
J Cachexia Sarcopenia Muscle. 2012 Mar;3(1):45-50. doi: 10.1007/s13539-012-0061-y. Epub 2012 Mar 2.
10
The obesity paradox in chronic disease: facts and numbers.慢性病中的肥胖悖论:事实与数据。
J Cachexia Sarcopenia Muscle. 2012 Mar;3(1):1-4. doi: 10.1007/s13539-012-0059-5. Epub 2012 Mar 14.